FCN1

FCN1 encodes M-ficolin (ficolin-1), a pattern-recognition molecule whose collagen-like domain directly binds the CH1 and CH3 domains of IgG1, an interaction mappable and competable with synthetic IgG1 domain peptides (PMID:28900133). Non-synonymous coding variants define its functional output: Ser268Pro abolishes M-ficolin production entirely, while Ala218Thr and Asn289Ser cripple its ligand-binding capacity, evidenced by reduced binding to Group B Streptococcus (PMID:23209787). Expression and secretion of ficolin-1 from monocytes are governed by FCN1 promoter polymorphisms at positions -542 and -144, which set both mRNA levels and secreted protein output (PMID:22673311). Within macrophages, FCN1 acts as a proinflammatory amplifier, promoting LPS-induced IL-1β maturation through the NLRP3–caspase-1 axis (PMID:36932401). Beyond these findings, the structural basis of complement activation by FCN1 has not been characterized in the available corpus.

1. 2012 Medium

   Establishing how FCN1 expression is set, promoter polymorphisms were shown to control transcript abundance and secreted ficolin-1, linking genetic variation to quantitative immune output.

   Evidence FCN1 promoter SNP genotyping with monocyte qRT-PCR and ELISA on culture supernatants

   PMID:22673311

   Open questions at the time

   • Transcription factors binding the -542/-144 region not identified
   • Functional consequence of altered ficolin-1 levels on complement activation not tested
2. 2012 High

   To connect coding variation with function, mutagenesis defined residues required for M-ficolin production versus ligand binding, distinguishing null from binding-deficient alleles.

   Evidence Recombinant protein expression of variant M-ficolin with Group B Streptococcus binding assay, corroborated by clinical genotype-phenotype data

   PMID:23209787

   Open questions at the time

   • Structural basis of how Ala218Thr/Asn289Ser impair binding not resolved
   • Effect on downstream complement activation not measured
3. 2017 Medium

   Addressing what M-ficolin recognizes beyond microbial ligands, its collagen-like domain was shown to directly bind IgG1, implicating it in antibody-associated recognition.

   Evidence In vitro Western blot binding assay with synthetic CH1/CH3 peptide inhibition

   PMID:28900133

   Open questions at the time

   • Physiological/in vivo relevance of the IgG1 interaction not established
   • Single lab, no reciprocal or structural validation
4. 2023 Medium

   Probing an intracellular/inflammatory role, FCN1 overexpression was found to enhance IL-1β maturation via NLRP3-caspase-1, positioning it as a proinflammatory amplifier in macrophages.

   Evidence FCN1 overexpression in THP-1-derived macrophages with immunoblotting for IL-1β, NLRP3, caspase-1

   PMID:36932401

   Open questions at the time

   • Gain-of-function only; loss-of-function not tested
   • Mechanism linking FCN1 to NLRP3 activation unknown
   • Single lab, single method

• How FCN1's pattern recognition couples mechanistically to lectin-pathway complement activation and to intracellular inflammasome signaling remains unresolved.
• No structural model of FCN1 ligand complexes
• Link between extracellular recognition and macrophage NLRP3 activation not established
• MASP partners and complement readouts not characterized in this corpus